Literature DB >> 12554378

Optimizing formulation factors in preparing chitosan microparticles by spray-drying method.

Y-C Huang1, C-H Chiang, M-K Yeh.   

Abstract

The chitosan only, chitosan/Pluronic F68, chitosan/gelatin, chitosan/Pluronic F68/gelatin microparticles and betamethasone-loaded chitosan/Pluronic F68/gelatin microparticles were successfully prepared by a spray-drying method. Microparticle characteristics (yield rate, zeta potential, particle size and tap density), loading efficiencies, microparticle morphology and in-vitro release properties were investigated. By properly choosing excipient type, concentration and varying the spray-drying parameters, a high degree of control was achieved over the physical properties of the dry chitosan powders. SEM micrograph shows that the particle sizes of the varied chitosan composed microparticles ranged from 2.12-5.67 microm and the external surfaces appear smooth. Using betamethasone as model drug, the spray-drying is a promising way to produce good spherical and smooth surface microparticles with a narrow particle size range for controlled delivery of betamethasone. The positively charged betamethasone-loaded microparticles entrapped in the chitosan/Pluronic F68/gelatin microparticles with trapping efficiencies up to 94.5%, yield rate 42.5% and mean particle size 5.64 microm varied between 4.32-6.20 microm and tap densities 0.128 g/cm(3). The pH of particle was increased with increasing betamethasone-loaded amount, but both zeta potential and tap density of the particles decreased with increasing betamethasone-loaded amount. The betamethasone release rates from chitosan/Pluronic F68/gelatin microparticles were influenced by the drug/polymer ratio in the manner that an increase in the release% and burst release% was observed when the drug loading was decreased. The in vitro release of betamethasone showed a dose-dependent burst followed by a slower release phase that was proportional to the drug concentration in the concentration range between 14-44%w/w.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12554378

Source DB:  PubMed          Journal:  J Microencapsul        ISSN: 0265-2048            Impact factor:   3.142


  7 in total

Review 1.  Pharmaceutical particle engineering via spray drying.

Authors:  Reinhard Vehring
Journal:  Pharm Res       Date:  2007-11-28       Impact factor: 4.200

2.  Development of budesonide microparticles using spray-drying technology for pulmonary administration: design, characterization, in vitro evaluation, and in vivo efficacy study.

Authors:  Sonali R Naikwade; Amrita N Bajaj; Prashant Gurav; Madhumanjiri M Gatne; Pritam Singh Soni
Journal:  AAPS PharmSciTech       Date:  2009-08-01       Impact factor: 3.246

3.  Preparation and Evaluation of Mucus-Penetrating Inhalable Microparticles of Tiotropium Bromide Containing Sodium Glycocholate.

Authors:  Yong-Bin Kwon; Ji-Hyun Kang; Young-Jin Kim; Dong-Wook Kim; Sung-Hoon Lee; Chun-Woong Park
Journal:  Pharmaceutics       Date:  2022-07-05       Impact factor: 6.525

4.  Formulation and evalution of montelukast sodium - chitosan based spray dried microspheres for pulmonary drug delivery.

Authors:  Rushi Panchal; Harsha Patel; Vishnu Patel; Pratik Joshi; Ankit Parikh
Journal:  J Pharm Bioallied Sci       Date:  2012-03

5.  Effects of chitosan and water-soluble chitosan micro- and nanoparticles in obese rats fed a high-fat diet.

Authors:  Hong-liang Zhang; Xiao-bin Zhong; Yi Tao; Si-hui Wu; Zheng-quan Su
Journal:  Int J Nanomedicine       Date:  2012-07-27

6.  Preparation of Chitosan and Water-Soluble Chitosan Microspheres via Spray-Drying Method to Lower Blood Lipids in Rats Fed with High-Fat Diets.

Authors:  Yi Tao; Hong-Liang Zhang; Yin-Ming Hu; Shuo Wan; Zheng-Quan Su
Journal:  Int J Mol Sci       Date:  2013-02-19       Impact factor: 5.923

7.  Design and Characterization of Spray-Dried Chitosan-Naltrexone Microspheres for Microneedle-Assisted Transdermal Delivery.

Authors:  Abayomi T Ogunjimi; Jennifer Fiegel; Nicole K Brogden
Journal:  Pharmaceutics       Date:  2020-05-29       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.